A global pharmaceutical platform with durable cash generation and uneven reported earnings
Takeda's multi-year record combines a broad revenue base with operating earnings that vary as intangible-asset amortization, impairments and restructuring shift. It generates substantial operating cash, while meaningful capital spending reduces the amount converted into free cash flow.